Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
The difference between the wild valuations and stock moves in the nascent pot industry and those of the turn-of-the-century dot-com stocks (Pets.com, anyone?) is that cannabis "is a market that actually exists," said financier Terry Taouss of cannabis financing company Tidal Royalty.
These are the headlines you Need 2 Know.
Naz Aletaha, head of esports partnerships for Riot Games, said that the "priceless" experiences with new global sponsor Mastercard will start with the world championships in October, offering premium content and behind the scenes access to the biggest event for esports lovers.
Raymond Wong, senior tech correspondent at Mashable, shares his thoughts on Apple's new iPhone XS, XS Max, and XR.
Shares of Tilray, the Canadian cannabis company, popped 50 percent Wednesday after the DEA cleared the way for its cannabis imports as part of a clinical trial. Those trials are the backbone of Tilray's strategy, said Bethany Gomez, director of research at Brightfield Group. As more countries permit medical marijuana research, Tilray is putting itself in pole position.
These are the headlines you Need 2 Know.
The popular courier service recently secured $300 million worth of funding at a $1.2 billion valuation. Kristin Schaefer, SVP of finance and strategy at Postmates, said that the company is eyeing next year for an IPO.
Apple appears to have dodged a bullet with the latest round of tariffs on Chinese imports. But if the trade war continues, the risks to the company get more serious, said Tom Forte, senior research analyst at D.A. Davidson. Apple currently gets 20 percent of its revenue from China
Elon Musk and SpaceX announced the company's first private passenger, Japanese billionaire Yusaku Maezawa. Shannon Stirone, freelance science journalist, said that this is the first step to Musk's ultimate goal ー transporting people to Mars.
Shortly after Audi unveiled its first all-electric SUV, the company announced a collaboration with Amazon and that its home services division will install charging stations at owners' homes for around $1,000. Filip Brabec, VP of product management for Audi of America, said Amazon's vetting of electricians and its "hassle-free" approach is what prompted the partnership.
